fluconazole has been researched along with Agnogenic Myeloid Metaplasia in 3 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with myelofibrosis complicated by recurrent candidemia died despite treatment with amphotericin B and fluconazole." | 1.30 | Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy. ( Matsumura, M; Mori, T; Oguri, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wysham, NG | 1 |
| Sullivan, DR | 1 |
| Allada, G | 1 |
| Maebashi, K | 1 |
| Kudoh, M | 1 |
| Nishiyama, Y | 1 |
| Makimura, K | 1 |
| Uchida, K | 1 |
| Mori, T | 2 |
| Yamaguchi, H | 1 |
| Matsumura, M | 1 |
| Oguri, T | 1 |
3 other studies available for fluconazole and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor.
Topics: Aged; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Enzyme Inhibitors; Fluconazole; Hu | 2013 |
A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candid | 2002 |
Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; DNA, Fungal; Drug Resistance, Microbial; Electr | 1998 |